Poor Science; Poorly Trained Scientists; Poor Policies: Major Deterrents to the War on Cancer
- Authors
-
-
Leslie C. Costello
School of Dentistry Department of Oncology and Diagnostic Sciences and the Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201, USA
-
- Keywords:
- Cancer, NIH policies, training of scientists, excessive molecular biology, holistic physiological/pathophysiological approach.
- Abstract
-
Although the availability of funding has been described as the major limitation on advances in cancer, the progress in the war on cancer has been deterred mainly by poor science, poorly trained scientists, and poor NIH policies. This is the result of NIH policies of its extreme focus on molecular biology (genomics, molecular genetics, molecular biology) identification of the molecular factors and pathways; which are required for the acceptability of treatment and preventive protocols. As such, this has influenced virtually all agencies that provide grants for medical research to adopt the NIH policies. This has impacted the funding of the research as well as the focus of the training of scientists. Directors of NCI Dr. Varmus (also Nobel Prize awardee) and Dr. Zerhouni had addressed this issue; and they rejected the necessity of molecular biology studies and information. NIH should return to the holistic physiological/pathophysiological approach to studies of cancer issues. This would provide the best approach for winning the war on cancer.
- Downloads
-
Download data is not yet available.
- References
-
Zerhouni E. The NIH roadmap. Science 2003; 332: 63-5. https://doi.org/10.1126/science.1091867
Leaf C. Why we're losing the war on cancer (and how to win it). Fortune 2004; 149(6): 76-82.
Costello LC. The effect of contemporary education and training of biomedical scientists on present and future medical research. Acad Med 2009; 84: 459-63. https://doi.org/10.1097/ACM.0b013e31819a7c6b
Perspective: Is NIH funding the "best science by the best scientists"? A critique of the NIH R01 research grant review policies. Acad Med 2010; 85(5): 775-9. https://doi.org/10.1097/ACM.0b013e3181d74256
National Institutes of Health. Enhancing Peer Review at NIH: Overview. Available at: http://enhancing-peer-review.nih.gov/index.html. Accessed January 18, 2010
Office of Extramural Research, National Institutes of Health. Encouraging Early Transition to Research Independence: Modifying the NIH New Investigator Policy to Identify Early Stage Investigators. Available at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-121.html. Accessed January 18, 2010.
Bernard C. An Introduction to the Study of Experimental Medicine. New York, NY: The Macmillan Company 1927.
- Downloads
- Published
- 15-08-2018
- Issue
- Vol. 7 No. 3 (2018)
- Section
- Articles
How to Cite
Similar Articles
- Altin Goxharaj, Nizom Suyunov, Evgeni Nikolaev, Aliia Bazhanova, Natalia Li, Current Developments and Innovations in Early Detection and Subsequent Treatment of Cancer , Journal of Cancer Research Updates: Vol. 13 (2024)
- Satoshi Hibi, Kenji Ina, Shu Yuasa, Nobuto Ito, Yuko Shirokawa, Kengo Nanya, Yuko Kato, Takashi Yoshida, Satoshi Kayukawa, Management of Hepatitis B Virus Reactivation after the Completion of Cancer Chemotherapy using a Plan-do-Check-Act Cycle , Journal of Cancer Research Updates: Vol. 11 (2022)
- L.R. Morgan, R.S. Weiner, M.L. Ware, M. Bhandari, T. Mahmood, P. Friedlander, Early Phase I Results for 4-Demethyl-4-cholesteryloxypenclo-medine [DM-CHOC-PEN] as Therapy in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies , Journal of Cancer Research Updates: Vol. 7 No. 3 (2018)
- Parvin Mehdipour, Multi-Phase Based Signature and Cancer Management: An Insight in Embryo, Brain Tumor, Leukemia, and Von Hippel Lindau Syndrome , Journal of Cancer Research Updates: Vol. 12 (2023)
- Jia-Jie Shi, Ling-Hua Meng, Autophagy in Cancer Therapy: Progress and Issues , Journal of Cancer Research Updates: Vol. 4 No. 1 (2015)
- Simona Di Francesco, Raffaele L. Tenaglia, Vascular Disease and Prostate Cancer: A Conflicting Association , Journal of Cancer Research Updates: Vol. 3 No. 1 (2014)
- Kamlesh Sodani, Amit K. Tiwari, Chun-Ling Dai, Alaa H. Abuznait, Atish Patel, Zhi-Jie Xiao, Charles R. Ashby, Amal Kaddoumi, Li-Wu Fu, Zhe-Sheng Chen, Sildenafil Enhances the Anticancer Activity of Paclitaxel in an ABCB1-Mediated Multidrug Resistance Xenograft Mouse Model , Journal of Cancer Research Updates: Vol. 3 No. 3 (2014)
- Hossein Mozdarani, Zainab Kouchak Mashkdouz, The Potent Regulatory Role of Circular RNAs in Breast Cancer Development, Diagnosis and Treatment: An Update , Journal of Cancer Research Updates: Vol. 11 (2022)
- Omar A. Dupuy L. , José A. Bonilla V., Renato Murillo M., Peter Taylor, María J. Abad, Lorena I. González P., Olmedo Otero, Johanna Juliao A., In Vitro Evaluation of the Antiinflammatory and Anticancer Activities of Compounds from the Plants Casearia sylvestris and Zanthoxylum monophyllum , Journal of Cancer Research Updates: Vol. 4 No. 3 (2015)
- Tchin Darré, Lantam Sonhaye, Mazamaesso Tchaou, Kokou Kanassoua, Abdoulatif Amadou, Aklesso Bagny, Alphonse Aman N’Guiessan, Koffi Amegbor, G. Napo-Koura, Histo-Epidemiological Profile of Digestive Cancers in Togo , Journal of Cancer Research Updates: Vol. 4 No. 3 (2015)
You may also start an advanced similarity search for this article.